The correlation between APOE ε4 and AD cerebrospinal fluid (CSF) biomarkers was explored by most studies (Lautner et al., 2014; Mattsson et al., 2018; Bussy et al., 2019; Konijnenberg et al., 2020; Benson et al., 2022). The gene discussed is APOE; the disease is Alzheimer disease.